Suit Over 'Illegal' CBD Products Paused To Await FDA Rules
A California federal court has paused a proposed class action accusing a CBD company of hawking products that aren't compliant with U.S. Food and Drug Administration guidelines, saying the case should...To view the full article, register now.
Already a subscriber? Click here to view full article